FIELD: clinical chemistry. SUBSTANCE: process for preparing aralkylamine derivatives of the general formula I , wherein X is hydrogen, (C1-C4) alkoxycarbonyl; R1 is (lower) alkyl ; R2 is unsubstituted phenyl or which may be substituted by one substituting group, hydroxyl or (C1-C4) alkoxy group, or two (C1-C4) alkoxy groups; m is 1,2; n is 2-6; A is six-member or five-member which is unsubstituted, or optionally substituted by oxo group or hydroxyl group, or A is ring of formula II ; B is benzene ring which may have three substitutes selected from a group consisting C1-C4 alkoxy group, OCH2O group or pyrrolidine group, or their acid addition salts is characterized by reacting compound of formula III , wherein Y is halogen; X is (C1-C4) alkoxycarbonyl; A ring is substituted by oxo group; B ring is as defined above or may be substituted by halo group, with compound of formula HN(R1)CH2R2, wherein R1 end R2 are as defined above followed by decarboxylation, if any, or if A ring is substituted by oxo group, by reduction of it to hydroxyl with subsequent splitting off, if any, such group, and reacting with pyrrolidine, provided that B ring is substituted by halo group. EFFECT: lower toxicity and higher inhibiting capacity to choline esterase. 3 tbl
Title |
Year |
Author |
Number |
ARALKYLAMINE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1992 |
- Goto Giiti[Jp]
- Nagaoka Akinobu[Jp]
- Isikhara Judzi[Jp]
|
RU2021256C1 |
DERIVATIVES OF QUINOLINE AND QUINAZOLINE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION |
1993 |
- Takasi Sokhda
- Kharukhiko Makino
- Atsuo Baba
|
RU2130934C1 |
METHOD OF SYNTHESIS OF QUINOLINE DERIVATIVE OR ITS SALT |
0 |
- Kandzi Meguro Khitosi Ikeda
|
SU1838301A3 |
ANTIHYPERTRIGLYCERIDEMIC COMPOSITION (VARIANTS), METHOD OF ITS PREPARING, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERTRIGLYCERIDEMIA |
1995 |
- Jasuo Sugijama
- Khidefumi Jukimasa
|
RU2166320C2 |
SULFUR-CONTAINING HETEROCYCLIC COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
1989 |
- Takasi Sokhda[Jp]
- Masao Tsuda[Jp]
- Ivao Jamazaki[Jp]
|
RU2041875C1 |
CONDENSED HETEROCYCLIC COMPOUNDS AND SQUALENE-SYNTHETASE INHIBITORS |
1994 |
- Khidefumi Jukimasa
- Rjuiti Tozava
- Jasuo Sugijama
- Masakuni Kori
|
RU2129547C1 |
HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO ANGIOTENSIN-II AND A METHOD OF ANTAGONIZATION OF ANGIOTENSIN-II IN MAMMALS |
1992 |
- Takekhiko Naka[Jp]
- Esijuki Finada[Jp]
|
RU2104276C1 |
DERIVATIVES OF 2,4-OXAZOLIDINEDIONE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALT, METHODS OF SYNTHESIS, MEDICINAL COMPOSITION SHOWING HYPOGLYCAEMIC AND HYPOLIPIDEMIC EFFECT, METHOD OF BLOOD GLUCOSE AND LIPID CONTENT DECREASE IN MAMMALIAN WITH DIABETES MELLITUS OR HYPERLIPIDEMIA |
1994 |
- Takasi Sokhda
- Khitosi Ikeda
- Ju Momose
- Satiko Imai
|
RU2126797C1 |
FUSED HETEROCYCLIC COMPOUNDS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1991 |
- Gijti Goto[Jp]
- Jjudzi Isakhara[Jp]
- Masaomi Mijamoto[Jp]
|
RU2095361C1 |
DERIVATIVES OF 4,1-BENZOXAZEPINE, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF ACTIVITY OF SQUALENE SYNTHETASE IN MAMMALS, METHOD OF INHIBITION OF FUNGI GROWTH IN MAMMALS |
1993 |
- Khidefumi Jukimasa
- Rjuiti Tozava
- Masakuni Kori
- Kazuaki Kitano
|
RU2145603C1 |